gastroesophageal junction adenocarcinoma

Showing 26 - 50 of 99

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Germany (5-Fluorouracil, Leucovorin, Oxaliplatin)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Aachen, Germany
  • +14 more
Sep 7, 2022

Clinical Stage II Esophageal Adenocarcinoma AJCC v8, Clinical Stage II Gastroesophageal Junction Adenocarcinoma AJCC v8,

Recruiting
  • Clinical Stage II Esophageal Adenocarcinoma AJCC v8
  • +27 more
  • Anchorage, Alaska
  • +469 more
Aug 24, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in United States (ELU001)

Recruiting
  • Ovarian Cancer
  • +68 more
  • Phoenix, Arizona
  • +8 more
Aug 18, 2022

Pancreatic Adenocarcinoma, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma Trial in United Kingdom, United States

Terminated
  • Pancreatic Adenocarcinoma
  • +13 more
  • San Francisco, California
  • +7 more
Aug 17, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Bemarituzumab, mFOLFOX6, Placebo)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Anchorage, Alaska
  • +140 more
Aug 11, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, cisplatin, 5-FU)

Completed
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • pembrolizumab
  • +3 more
  • (no location specified)
Jul 13, 2022

Gastric Adenocarcinoma, Esophagus Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in France

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Amiens, France
  • +20 more
Jul 26, 2022

Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • Claudin 18.2 CAR-T
  • (no location specified)
Jul 21, 2022

Esophagogastric Tumors, Gastric Cancer, Gastric Tumor Trial in United States (Trastuzumab, Pembrolizumab)

Recruiting
  • Esophagogastric Tumors
  • +9 more
  • Basking Ridge, New Jersey
  • +6 more
Jul 8, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Gyeonggi-do, Seoul (GEN-001, Avelumab)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Gyeonggi-do, Korea, Republic of
  • +4 more
Jun 14, 2022

Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Multiple Locations

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • +3 more
  • Routine care as per site standard
  • Multiple Locations, Germany
    Multiple sites, Gemany
Jun 3, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial (pembrolizumab, paclitaxel)

Completed
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
May 12, 2022

Gastric Adenocarcinoma, Pancreatic Cancer, Gastroesophageal Junction Adenocarcinoma Trial (CT048 Autologous Injection (CT048))

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • CT048 Autologous Injection (CT048)
  • (no location specified)
May 24, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Esophageal Adenocarcinoma Trial in Kashiwa (Regorafenib,

Not yet recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Kashiwa, Chiba, Japan
    National Cancer Center Hospital East
May 23, 2022

Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7 Trial in Phoenix,

Active, not recruiting
  • Gastric Cardia Adenocarcinoma
  • +7 more
  • Phoenix, Arizona
  • +1 more
May 12, 2022

Advanced Solid Tumor, NSCLC, Melanoma Trial in United States (AB308, Zimberelimab)

Recruiting
  • Advanced Solid Tumor
  • +9 more
  • Phoenix, Arizona
  • +20 more
May 2, 2022

Collecting Blood Samples From and Without Cancer to Evaluate

Not yet recruiting
  • Acute Lymphoblastic Leukemia
  • +61 more
  • Questionnaire Administration
  • Biospecimen Collection
  • (no location specified)
Apr 12, 2022

Gastric Cancer, Cancer of Stomach, Gastric Adenocarcinoma Trial in Woodville South (IMU-131, Irinotecan or Paclitaxel,

Not yet recruiting
  • Gastric Cancer
  • +5 more
  • IMU-131
  • +2 more
  • Woodville South, South Australia, Australia
    The Queen Elizabeth Hospital
Apr 12, 2022

Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)

Active, not recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Adenocarcinoma
  • Frankfurt, Germany
  • +1 more
Apr 14, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Peritoneal Carcinomatosis Trial in Houston (Cisplatin,

Active, not recruiting
  • Gastric Adenocarcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Apr 12, 2022

Gastric Tumors, Gastroesophageal Junction Adenocarcinoma Trial in Worldwide (Pembrolizumab, Paclitaxel)

Terminated
  • Gastric Neoplasms
  • Gastroesophageal Junction Adenocarcinoma
  • Beijing, Beijing, China
  • +35 more
Apr 1, 2022

Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma Trial in Kashiwa (Trastuzumab Deruxtecan (T-DXd))

Recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • Trastuzumab Deruxtecan (T-DXd)
  • Kashiwa, Chiba, Japan
    National Cancer Center Hospital East
Apr 5, 2022

The Tumor Microenvironment for Locally Advanced Resectable

Recruiting
  • Gastric Adenocarcinoma
  • Gastroesophageal Junction Adenocarcinoma
  • non-intervention
  • Guangzhou, Guangdong, China
    Nanfang Hospital, Southern Medical University
Mar 24, 2022

Stomach Cancer, Stomach Tumor, Gastric Cancer Trial in France (Ramucirumab, Paclitaxel)

Recruiting
  • Stomach Cancer
  • +3 more
  • Abbeville, France
  • +37 more
Mar 23, 2022